Online, 30/05/2022.

An extraordinary General Assembly (GA) meeting took place on 30^th May 2022 throughout video conference system with the attendance of 28 participants belonging to the 19 project partner organizations.

Bergamo, 24-25/05/2022.

iToBoS project was presented in Liquid Biopsies Congress 2022 of European Association for Cancer Research (EACR).

Lisbon, 14/05/2022.

iToBoS project was presented in Bootcamp22 Research Strategy workshop in the framework of the Leibniz University Hannover (LUH) work within the project.

Singapore, 6-8/05/2022.

iToBoS project was presented at the conference "Environmental/ host factors and clinical heterogeneity in skin melanoma: the need of a holistic diagnostic tool", in the World Cancer Research Symposium (SCWR 2022).

Porto, 20-23/04/2022.

The iToBoS project was presented at the 1^st Spring Biophotonics Conference in Porto (OPORTO22), through the conference titled “Multimodal optical systems for the investigation of skin diseases”.

Barcelona, 31/03/2022.

iToBoS was presented in the framework of a course of the Academia Española de Dermatologia y Venereologia (AEDV) in Barcelona, Spain, on March 31, 2022. 

Online, 31/03/2022.

iToBoS project has launched ai4pa (Artificial Intelligence For Patient Advocates) consisting in a training module oriented to patient advocates that serves as an introduction to transparent and explainable AI and its policy context.

Online, 9/03/2022.

The iToBoS 2^nd Project Management Board (PMB) meeting took place on 9/03/2022 throughout video conference system with the attendance of 17 attendees.

Barcelona, 28/02 - 8/03, 2022. 

iToBoS presents the objectives, challenges and expected benefits of the project at the MWC Open Innovation Challenge 2022 among a wide and multidisciplinary audience.

Barcelona, 28/02 - 3/03, 2022. 

iToBoS project was presented in the 4 Years From Now (4YFN) Congress, held in Barcelona from February 28 to March 3, 2022.